Four company notes:
1. The cessation of elective surgeries in April were the primary cause of the decrease in second quarter revenue, according to the company.
2. Net income was $30,000 in the second quarter, up from a loss of $40,000 the previous year.
3. Gross margins on total revenues were 40.9 percent for the second quarter, compared to 34.6 percent in the first quarter of fiscal 2020 and 39.5 percent for the second quarter in 2019.
The company attributes the improvement to its strategy of converting third party product sales to “more proprietary Aurora spine products.”
4. Aurora Spine completed designs for a posterior sacroiliac joint fusion product and the ZIP-Flex interlamar fixation device.
More articles on devices:
Meet Elon Musk’s surgical robot
Laser Spine Institute 18 months after closure — What happened to its $56M Tampa HQ?
Vertebral body tethering shows success in the treatment of scoliosis, study finds
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
